Company Filing History:
Years Active: 2004-2010
Title: The Innovations of Mathijs Baens
Introduction
Mathijs Baens is a notable inventor based in Lubbeek, Belgium. He has made significant contributions to the field of biotechnology, particularly in the molecular characterization of chromosome translocations and their implications in carcinogenesis. His work has led to advancements in understanding malignancies such as mucosa-associated lymphoid tissue (MALT) lymphomas.
Latest Patents
Mathijs Baens holds 2 patents that focus on the molecular characterization of chromosome translocation t(11;18)(q21;q21). His latest patents include methods for determining whether a tissue sample comprises a cell with a chromosome (11:18) translocation associated with malignancies. These inventions provide insights into a novel mechanism of transformation of primary cells, involving the expression of a fusion proteinaceous molecule that includes apoptosis inhibitor 2 (API2) fused to other proteinaceous molecules. Additionally, he has developed a novel nucleic acid sequence and a proteinaceous molecule termed 'MALT-lymphoma associated Translocation (MLT) protein.'
Career Highlights
Mathijs Baens is affiliated with the Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of genetic factors in cancer, particularly in relation to MALT lymphomas.
Collaborations
Throughout his career, Mathijs has collaborated with esteemed colleagues such as Judith Dierlamm and Peter Marijnen. These collaborations have enriched his research and contributed to the success of his innovative projects.
Conclusion
Mathijs Baens is a prominent figure in the field of biotechnology, with a focus on cancer research and molecular characterization. His patents and collaborative efforts continue to influence advancements in understanding and treating malignancies.